Growing community of inventors

Atlanta, GA, United States of America

Leon H Zalkow

Average Co-Inventor Count = 3.91

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 231

Leon H ZalkowRudiger D Haugwitz (5 patents)Leon H ZalkowHoward M Deutsch (4 patents)Leon H ZalkowVenkatachala L Narayanan (3 patents)Leon H ZalkowJan Glinski (2 patents)Leon H ZalkowMathew Suffness (2 patents)Leon H ZalkowEwa Gruszecka-Kowalik (1 patent)Leon H ZalkowEdward Burgess (1 patent)Leon H ZalkowHairuo Peng (1 patent)Leon H ZalkowLeslie Gelbaum (1 patent)Leon H ZalkowVenkatachala Naratanan (1 patent)Leon H ZalkowLeon H Zalkow (6 patents)Rudiger D HaugwitzRudiger D Haugwitz (14 patents)Howard M DeutschHoward M Deutsch (4 patents)Venkatachala L NarayananVenkatachala L Narayanan (8 patents)Jan GlinskiJan Glinski (2 patents)Mathew SuffnessMathew Suffness (2 patents)Ewa Gruszecka-KowalikEwa Gruszecka-Kowalik (3 patents)Edward BurgessEdward Burgess (1 patent)Hairuo PengHairuo Peng (1 patent)Leslie GelbaumLeslie Gelbaum (1 patent)Venkatachala NaratananVenkatachala Naratanan (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. The United States of America As Represented by the Department of Health (4 from 1,215 patents)

2. Georgia Tech Research Corporation (2 from 2,082 patents)

3. The United States of America As Represented by the Secretary of (1 from 2,202 patents)


6 patents:

1. 6011058 - Seco-cholestane derivatives and methods of making the same

2. 5681832 - Aroylaniline compounds, pharmaceutical compositions, and methods of

3. 5157049 - Method of treating cancers sensitive to treatment with water soluble

4. 4942184 - Water soluble, antineoplastic derivatives of taxol

5. 4803202 - Substituted N-methyl derivatives of mitindomide

6. 4670461 - Formaldehyde derivatives of mitindomide

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/16/2025
Loading…